KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Adaptive Biotechnologies (ADPT) Depreciation & Amortization (IS) (2023 - 2025)

Adaptive Biotechnologies' Depreciation & Amortization (IS) history spans 3 years, with the latest figure at $3.7 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) fell 7.1% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.6 million, a 12.57% decrease, with the full-year FY2025 number at $16.0 million, down 8.26% from a year prior.
  • Depreciation & Amortization (IS) hit $3.7 million in Q4 2025 for Adaptive Biotechnologies, down from $4.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for ADPT hit a ceiling of $5.8 million in Q3 2023 and a floor of $2.8 million in Q4 2023.
  • Historically, Depreciation & Amortization (IS) has averaged $4.5 million across 3 years, with a median of $4.2 million in 2024.
  • The widest YoY moves for Depreciation & Amortization (IS): up 42.43% in 2024, down 27.88% in 2024.
  • Tracing ADPT's Depreciation & Amortization (IS) over 3 years: stood at $2.8 million in 2023, then soared by 42.43% to $3.9 million in 2024, then fell by 7.1% to $3.7 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for ADPT at $3.7 million in Q4 2025, $4.0 million in Q3 2025, and $4.1 million in Q2 2025.